Martin’s tenure at the company spans back to 2009, when he first joined the finance team. He ascended to the role of CFO in 2017, overseeing the organization's fiscal strategy during a period of significant growth. Anthony Marucci, Celldex’s co-founder and chief executive, credited Martin with guiding the company through its evolution from an early-stage research outfit into a late-stage leader in the immunology sector.
Celldex CFO Sam Martin to Retire Following Long Tenure
After fifteen years of financial stewardship, Sam Martin is stepping down as chief financial officer of Celldex Therapeutics. The clinical-stage biopharmaceutical firm confirmed on Wednesday that it has launched a formal search for his successor, aiming to finalize the transition before his planned departure this March.
When reusing this material a link to Money Talk is required.
Comments (0)
No comments yet. Be the first!